Chemed to report third quarter 2021 results on October 28, related conference call to be held on October 29
CINCINNATI – (COMMERCIAL THREAD) – Chemed Corporation (NYSE: CHE) announced today that it will release financial results for the third quarter ended September 30, 2021, on Thursday, October 28, 2021, after trading on the New York Stock Exchange closes.
Chemed will host a conference call and webcast at 10 a.m. ET on Friday, October 29, 2021 to discuss the company’s quarterly results and provide an update on its business.
The toll-free number for the conference call is 844-743-2500 for US and Canadian participants and +1 661-378-9533 for international participants. The participant’s conference ID is 6082999. A live webcast of the call can be viewed on Chemed’s website at www.chemed.com by clicking on Investor Relations Home.
A recorded replay of the conference call will be available from approximately two hours after the call ends. It can be reached by dialing the toll-free number 855-859-2056 for US and Canadian callers and +1 404-537-3406 for international callers and will be available for one week after the live call. The replay conference ID is 6082999. An archived webcast will also be available at www.chemed.com.
Listed on the New York Stock Exchange and based in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the largest national provider of end-of-life palliative care and Roto-Rooter is the leading national provider of plumbing and drain cleaning services.
Statements in this press release or in other communications from Chemed may relate to future events or the future performance of Chemed. These statements are forward-looking statements and are based on current information that Chemed has related to its current business condition. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. In addition, investors are cautioned that Chemed assumes no obligation to update forward-looking statements based on unforeseen events or changes in expectations.